Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.

@article{Vannice2018FractionalDoseYF,
  title={Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.},
  author={Kirsten S. Vannice and Annelies Wilder-Smith and Joachim M Hombach},
  journal={The New England journal of medicine},
  year={2018},
  volume={379 7},
  pages={
          603-605
        }
}
Fractional-Dose Yellow Fever Vaccination During major yellow fever outbreaks in 2016, the Democratic Republic of Congo was faced with the options of using off-label fractional-dose vaccine to meet the supply needs or using the full-dose vaccine but leaving millions of people at risk for yellow fever. 
Fractional-dose yellow fever vaccination: an expert review
TLDR
Findings indicate that if a person mounts a protective response shortly after vaccination, the protective response will persist for 10 years and possibly longer, and it appears that fractional-dose vaccination does not elicit more serious adverse events than standard dose vaccination.
Yellow fever virus: historical and current issues regarding recent epidemics and vaccination in Brazil
TLDR
Immunization with a fractional dose of vaccine during emergency situations needs to be evaluated for antibody duration, and new and improved vaccines should be considered.
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomized, double-blind, non-inferiority trial
TLDR
These results support fractional dosing of all WHO-prequalified yellow fever vaccines for the general adult population for outbreak response in situations of vaccine shortage.
Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines
TLDR
The live-attenuated vaccine’s limitations are reviewed and the epitome of a yellow fever vaccine is explored, whilst scrutinizing next-generation vaccine candidates.
Boosting Global Yellow Fever Vaccine Supply for Epidemic Preparedness: 3 Actions for China and the USA
TLDR
These vaccines could be made available nationally, regionally, and globally through the ICG, e.g., to help stop and prevent epidemics anywhere in the world.
A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose
This commentary discusses the pros and cons of single-dose COVID-19 vaccination versus the 2-dose strategy.
Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever
TLDR
The changing epidemiology of YF outbreaks is described, the use of public health policies, therapeutics, and vaccination as tools to help eliminate future YFV outbreaks are highlighted, and the potential fear of YfV emerging as a global threat is highlighted.
Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever
TLDR
The changing epidemiology of YF outbreaks is described and the use of public health policies, therapeutics, and vaccination as tools to help eliminate future YFV outbreaks are highlighted.
Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children
ABSTRACT Background: The World Health Organization recommends use of a single yellow fever (YF) vaccine dose for life and fractional doses in outbreaks when there are limited vaccine stocks. In
...
...

References

SHOWING 1-5 OF 5 REFERENCES
Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
TLDR
Analysis of serum biomarkers IFN-γ and IL-10, in association to PRNT and viremia, support the recommendation of use of a ten-fold lower subdose (3,013 IU) of 17DD-YF vaccine.
Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Preliminary Report.
TLDR
A fractional dose of the 17DD yellow fever vaccine was effective at inducing seroconversion in most of the participants who were seronegative at baseline, and these findings support the use of fractional-dose vaccination for outbreak control.
17DD Yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose­response study
  • Hum Vaccin Immunother
  • 2013